✦ LIBER ✦

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Scribed by Susan C. Modesitt; Michael Sill; James S. Hoffman; David P. Bender

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II evaluation of dasatinib in the

✍ Russell J. Schilder; William E. Brady; Heather A. Lankes; James V. Fiorica; Mark 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 205 KB

A phase II evaluation of lapatinib in th

✍ Agustin A. Garcia; Michael W. Sill; Heather A. Lankes; Andrew K. Godwin; Robert 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 220 KB

A phase II evaluation of mifepristone in

✍ Thomas F. Rocereto; William E. Brady; Mark S. Shahin; James S. Hoffman; Laurie S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase II study of a urokinase-derived

✍ Michael A. Gold; William E. Brady; Heather A. Lankes; Peter G. Rose; Joseph L. K 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 257 KB

A phase II trial of paclitaxel poliglume

✍ Paul Sabbatini; Michael W. Sill; David O'Malley; Lisa Adler; Angeles Alvarez Sec 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 305 KB

A phase II evaluation of belinostat and

✍ Don S. Dizon; John A. Blessing; Richard T. Penson; Richard D. Drake; Joan L. Wal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 197 KB